Family Legacy Inc’s GSK GSK Stock Holding History

Family Legacy Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,400	Closed	-$262K	–	122
2024 Q3	$262K	Hold	6,400	–	–	0.09%	117
2024 Q2	$246K	Hold	6,400	–	–	0.09%	116
2024 Q1	$274K	Hold	6,400	–	–	0.1%	111
2023 Q4	$237K	Hold	6,400	–	–	0.09%	113
2023 Q3	$232K	Hold	6,400	–	–	0.1%	111
2023 Q2	$228K	Hold	6,400	–	–	0.09%	110
2023 Q1	$228K	Hold	6,400	–	–	0.1%	110
2022 Q4	$225K	Buy	+6,400	New	+$213K	0.1%	108
2022 Q3	–	Sell	-6,400	Closed	-$332K	–	109
2022 Q2	$332K	Hold	6,400	–	–	0.16%	99
2022 Q1	$348K	Hold	6,400	–	–	0.15%	103
2021 Q4	$360K	Hold	6,400	–	–	0.15%	103
2021 Q3	$310K	Hold	6,400	–	–	0.14%	105
2021 Q2	$314K	Hold	6,400	–	–	0.14%	104
2021 Q1	$286K	Sell	6,400 -140	-2%	-$6.35K	0.14%	105
2020 Q4	$301K	Hold	6,540	–	–	0.16%	102
2020 Q3	$308K	Hold	6,540	–	–	0.17%	97
2020 Q2	$333K	Hold	6,540	–	–	0.2%	98
2020 Q1	$310K	Hold	6,540	–	–	0.22%	92
2019 Q4	$379K	Hold	6,540	–	–	0.22%	98
2019 Q3	$361K	Hold	6,540	–	–	0.23%	97
2019 Q2	$327K	Hold	6,540	–	–	0.26%	91
2019 Q1	$341K	Hold	6,540	–	–	0.28%	89
2018 Q4	$312K	Hold	6,540	–	–	0.28%	86
2018 Q3	$328K	Sell	6,540 -2,640	-29%	-$134K	0.27%	88
2018 Q2	$463K	Hold	9,180	–	–	0.4%	71
2018 Q1	$448K	Hold	9,180	–	–	0.41%	69
2017 Q4	$407K	Buy	9,180 +2,780	+43%	+$128K	0.37%	75
2017 Q3	$325K	Sell	6,400 -3,020	-32%	-$153K	0.83%	36
2017 Q2	$508K	Sell	9,420 -625	-6%	-$33.3K	0.51%	61
2017 Q1	$529K	Buy	+10,045	New	+$510K	0.55%	56

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Family Legacy Inc's GSK Position: Q4 2024 in Review

Family Legacy Inc sold out of GSK (GSK) in Q4 2024, closing a stake of 6,400 shares — an estimated $262K sold.

Family Legacy Inc first reported a position in GSK in Q1 2017 and held it in 30 quarters. The position peaked at $529K in Q1 2017. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Family Legacy Inc reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Family Legacy Inc sold 6,400 GSK shares in Q4 2024, an estimated $262K.
Family Legacy Inc first reported a position in GSK in Q1 2017 and held it in 30 quarters.
Family Legacy Inc's GSK position peaked at $529K in Q1 2017.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Family Legacy Inc's 13F filing for Q4 2024, filed 12 Feb 2025.